Table of Contents

Clinical Studies

• Open Access

  Extracellular Vesicle DNA Extraction and Sequencing in Ancient Serum Samples From Patients With Breast Cancer

  MARTIN HEIDINGER, DANIEL EGLE, SALVATORE PISCUOGLIO, MIGUEL ÁNGEL NAVARRO-AGUADERO, SARA SÁNCHEZ, MARTA HERGUETA-REDONDO, MIGUEL GALLARDO, SANTIAGO BARRIO, BEATRIZ GARCÍA-PELÁEZ, MIGUEL ANGEL MOLINA-VILA, NADIA MAGGI, RUTH STEFANIE ELLER, JULIE MARIE LOESCH, ILARIA ALBORELLI, HECTOR PEINADO, WALTER WEBER and WALTER PAUL WEBER

  Anticancer Research July 2024, 44 (7) 2981-2988; DOI: https://doi.org/10.21873/anticanres.17110
• Open Access

  Prophylactic Effect of Clarithromycin on Radiation Pneumonitis in IMRT for Lung Cancer

  TAKAYUKI OHGURI, TAKAHIRO MORISAKI, HIROHIDE ITAMURA, SUBARU TANI, KAZUHIRO YATERA and FUMIHIRO TANAKA

  Anticancer Research July 2024, 44 (7) 2989-2995; DOI: https://doi.org/10.21873/anticanres.17111
• Open Access

  Correlation Between Blood Levels of Cysteine Protease Caspase-1 (Casp1) and Pain Scores (NRS) Post-surgery: A Prospective Randomized Study of Patients With Cholelithiasis

  MAARET ESKELINEN, TUOMAS SELANDER, JUKKA PULKKINEN, ANU HOLOPAINEN, ESA HÄMÄLÄINEN and MATTI ESKELINEN

  Anticancer Research July 2024, 44 (7) 2997-3003; DOI: https://doi.org/10.21873/anticanres.17112
• You have access

  Higher YAP1 Levels Are Associated With Shorter Survival of Patients With Low Grade Astrocytoma

  JILL DICKE, LAURA HERO, SASKIA KUHL, LUKAS GÖRTZ, ROLAND GOLDBRUNNER and MARCO TIMMER

  Anticancer Research July 2024, 44 (7) 3005-3011; DOI: https://doi.org/10.21873/anticanres.17113
• You have access

  Risks and Outcomes of Early Dose Reduction in Adjuvant CAPOX Therapy for Colorectal Cancer

  IKUMA SHIOI, HIROOMI OGAWA, RYOZAN NAITO, MIZUKI ENDO, NOBUHIRO HOSOI, KOHEI TATENO, SHINTARO UCHIDA, ARISA YAMAGUCHI, TAKAYOSHI WATANABE, NOBUHIRO NAKAZAWA, YUTA SHIBASAKI, CHIKA KOMINE, TAKUYA SHIRAISHI, KATSUYA OSONE, TAKUHISA OKADA, AKIHIKO SANO, MAKOTO SAKAI, MAKOTO SOHDA, KEN SHIRABE and HIROSHI SAEKI

  Anticancer Research July 2024, 44 (7) 3013-3023; DOI: https://doi.org/10.21873/anticanres.17114
• Open Access

  Cutaneous and Renal Toxicities of Enfortumab Vedotin for Advanced Urothelial Carcinoma: The UROKYU Study

  NOBUKI FURUBAYASHI, AKINORI MINATO, TOSHIHISA TOMODA, HIROYUKI MASAOKA, YOSHIFUMI HORI, KEIJIRO KIYOSHIMA, TAKAHITO NEGISHI, YUSUKE HARAGUCHI, TOSHIKI KOGA, YOOHYUN SONG, KENICHI HARADA, KENTARO KUROIWA, NARIHITO SEKI, NAOHIRO FUJIMOTO, MOTONOBU NAKAMURA and Uro-Oncology Group in Kyushu (UROKYU)

  Anticancer Research July 2024, 44 (7) 3025-3032; DOI: https://doi.org/10.21873/anticanres.17115
• You have access

  Autologous Peripheral Blood Stem Cell Transplantation and Timing of Local Radiation Therapy in Patients With Malignant Lymphoma: Results of the Japanese Radiation Oncology Study Group Questionnaire Survey

  NAOYA ISHIBASHI, YASUO EJIMA, TOSHINORI SOEJIMA, HIROKI KAWAGUCHI, SENZO TAGUCHI, HITOSHI ITO, TAKUYA SHIMIZUGUCHI, KOUICHI ISOBE, MASATOSHI HASEGAWA, KEISUKE SASAI, MICHIKO IMAI, EMIKO SHIMODA, HISASHI KAIZU, NAOKO OKANO, TOSHIYUKI IMAGUMBAI and TETSUO AKIMOTO

  Anticancer Research July 2024, 44 (7) 3033-3041; DOI: https://doi.org/10.21873/anticanres.17116
• You have access

  First Clinical Safety and Feasibility Data of Whole-body Hyperthermia Pressurized Intraperitoneal Aerosol Chemotherapy (WBH-PIPAC) for Peritoneal Surface Malignancies

  FABIAN KOCKELMANN, URS GIGER-PABST, MEHDI OUAISSI, PETRU BUCUR, SARAH BARBEY, ALEXANDER VON ARDENNE and JÜRGEN ZIEREN

  Anticancer Research July 2024, 44 (7) 3043-3050; DOI: https://doi.org/10.21873/anticanres.17117
• Open Access

  Contribution of Matrix Metalloproteinase-7 Genotypes to Endometriosis Risk in Taiwan

  HUNG-JU CHIEN, YUN-CHI WANG, WEN-SHIN CHANG, YI-HSIEN HSIEH, YEN-FANG LIU, YA-CHEN YANG, JAW-CHYUN CHEN, DA-TIAN BAU and CHIA-WEN TSAI

  Anticancer Research July 2024, 44 (7) 3051-3058; DOI: https://doi.org/10.21873/anticanres.17118
• Open Access

  Prognostic Factors for Progression-free Survival and Overall Survival After Recurrence of Glioblastoma

  OKSANA ZEMSKOVA, NATHAN Y. YU, JAN LEPPERT and DIRK RADES

  Anticancer Research July 2024, 44 (7) 3059-3066; DOI: https://doi.org/10.21873/anticanres.17119
• You have access

  A Retrospective Analysis of Systemic Oncologic Treatment in Older Patients With Advanced Soft-tissue Sarcoma

  JASMIINI LEMMA, JASMIN LILJESTRÖM, MIKA SAMPO, RIIKKA NEVALA, CARL BLOMQVIST, MOHAMED ELMEGIRI and SARI JÄÄMAA

  Anticancer Research July 2024, 44 (7) 3067-3075; DOI: https://doi.org/10.21873/anticanres.17120
• You have access

  Analysis of Treatment Response With Proteins Related to Tumor Immunity in Postoperative Irradiated Cervical Cancer Patients

  SHOH MAFUNE, MASANORI SOMEYA, TOMOKAZU HASEGAWA, TAKAAKI TSUCHIYA, MIO KITAGAWA, TOSHIO GOCHO, RYU OKUDA, MASAHIRO IWASAKI, MOTOKI MATSUURA, TERUFUMI KUBO, YOSHIHIKO HIROHASHI, TOSHIHIKO TORIGOE, TSUYOSHI SAITO and KOH-ICHI SAKATA

  Anticancer Research July 2024, 44 (7) 3077-3086; DOI: https://doi.org/10.21873/anticanres.17121
• You have access

  Clinical Association Between Immune-related Adverse Events and Treatment Efficacy in Patients With Non-small-cell Lung Cancer Treated With Nivolumab-Ipilimumab-based Therapy

  NORIYUKI EBI, HIROYUKI INOUE, FUMIYASU IGATA, REI OKUMA, ERIKO KINOSHITA, TOSHIAKI KAWABATA, IBUN TAN, YUSUKE OSAKI, TAKATO IKEDA, AKIRA NAKAO, YUKI SHUNDO, NAOKI HAMADA and MASAKI FUJITA

  Anticancer Research July 2024, 44 (7) 3087-3095; DOI: https://doi.org/10.21873/anticanres.17122
• You have access

  Current Status of Conversion Hepatectomy After Sorafenib and Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma

  SHOHEI KOMATSU, YOSHIHIKO YANO, TAKUYA MIMURA, AKIHIRO MINAMI, KENJI MOMOSE, HIROTAKA HIRANO, MOTOFUMI TANAKA, YUKI UEDA, KENTARO TAI, YUKI YASUHARA, DAISUKE NAKAGAWA, ATSUSHI YAMAMOTO, MASAHIRO KIDO, YOSHIHIDE UEDA, YUZO KODAMA and TAKUMI FUKUMOTO

  Anticancer Research July 2024, 44 (7) 3097-3103; DOI: https://doi.org/10.21873/anticanres.17123
• You have access

  Evaluation of Serum Cytokeratines, Thymidine Kinase, and Growth Factors as Cancer Biomarkers in Colorectal Cancer

  MARIE KARLÍKOVÁ, MAGDA ČURILLOVÁ, LADISLAV PECEN, VÁCLAV KARNOS, VÁCLAV KARNOS and ONDŘEJ TOPOLČAN

  Anticancer Research July 2024, 44 (7) 3105-3113; DOI: https://doi.org/10.21873/anticanres.17124
• You have access

  Clinical Value of Fine Needle Aspiration Cytology and Core Needle Biopsy in Head and Neck Pathology – A Nationwide Survey in Germany

  URBAN W. GEISTHOFF, FREYA DROEGE, CATHERINE HAND, LAURA C. HOLTMANN, STEFAN MATTHEIS, STEPHAN HOCH, STEPHAN LANG, BORIS A. STUCK, ORLANDO GUNTINAS-LICHIUS and STEFAN A. RUDHART

  Anticancer Research July 2024, 44 (7) 3115-3124; DOI: https://doi.org/10.21873/anticanres.17125
• You have access

  Ramucirumab Beyond Disease Progression After Paclitaxel Plus Ramucirumab in Gastric Cancer: A Phase II Trial

  YASUYOSHI SATO, HIROHARU YAMASHITA, KOICHI YAGI, SACHIYO NOMURA and YASUYUKI SETO

  Anticancer Research July 2024, 44 (7) 3125-3131; DOI: https://doi.org/10.21873/anticanres.17126
• You have access

  Optimizing Therapeutic Approaches in Superficial Esophageal Cancer: Reduced-volume Radiotherapy and Dose-dense Chemotherapy After Endoscopic Resection

  GEN SUZUKI, HIDEYA YAMAZAKI, NORIHIRO AIBE, KOJI MASUI, TAKUYA KIMOTO, SHINSUKE NAGASAWA, KANAKO KAWABATA, TOMOHIRO KAJIKAWA, YUKI YOSHINO, SHO SERI, AKITO ASATO, OSAMU DOHI, TAKESHI ISHIKAWA, ETSUYO OGO, HANY ELSALEH and KEI YAMADA

  Anticancer Research July 2024, 44 (7) 3133-3139; DOI: https://doi.org/10.21873/anticanres.17127
• You have access

  Association of BRAF or TERT Promoter Mutations and Advanced Papillary Thyroid Carcinoma

  SOJI TODA, NAO SAITO, MEI KADOYA, YOICHIRO OKUBO, HARUHIKO YAMAZAKI, NOBUYASU SUGANUMA, HIROYUKI IWASAKI, KATSUHIKO MASUDO and DAISUKE HOSHINO

  Anticancer Research July 2024, 44 (7) 3141-3147; DOI: https://doi.org/10.21873/anticanres.17128
• Open Access

  Predictive Factors for Early Biochemical Recurrence Following Robot-assisted Radical Prostatectomy

  KENSUKE MITSUNARI, HAJIME FUKUSHIMA, HIROKI KURATA, JUNKI HARADA, YUICHIRO NAKAMURA, TOMOHIRO MATSUO, KOJIRO OHBA, YASUSHI MOCHIZUKI and RYOICHI IMAMURA

  Anticancer Research July 2024, 44 (7) 3149-3154; DOI: https://doi.org/10.21873/anticanres.17129
• You have access

  Impact of Novel Agents on Patient Characteristics, Treatment Patterns, and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer

  YUTAKA YAMAMOTO, MITUHISA NISHIMOTO, YASUNORI AKASHI, KEISUKE KIBA, TAKAFUMI MINAMI, MASAHIRO NOZAWA, KAZUHIRO YOSHIMURA, AKIHIDE HIRAYAMA, HIROTSUGU UEMURA and KAZUTOSHI FUJITA

  Anticancer Research July 2024, 44 (7) 3155-3161; DOI: https://doi.org/10.21873/anticanres.17130
• You have access

  Comparative Analysis of Clinical Characteristics and Prognosis Between Primary Lung Cancers Identified as Screening Detected and Incidentally Detected Pulmonary Nodules

  SUNGMIN ZO, CHOHEE KIM, HO YUN LEE, GYEONGMI PARK, SUN HYE SHIN, BYEONG-HO JEONG, KYUNGJONG LEE, HOJOONG KIM, HONG KWAN KIM and SANG-WON UM

  Anticancer Research July 2024, 44 (7) 3163-3173; DOI: https://doi.org/10.21873/anticanres.17131
• You have access

  Comparison of Real-world Efficacy and Safety of Atezolizumab and Durvalumab in Combination With Chemotherapy for First-line Treatment of Extensive-stage Small-cell Lung Cancer

  FUMIYASU IGATA, HIROYUKI INOUE, TAKATO IKEDA, AKIRA NAKAO, NORIYUKI EBI and MASAKI FUJITA

  Anticancer Research July 2024, 44 (7) 3175-3183; DOI: https://doi.org/10.21873/anticanres.17132
• You have access

  Clinical Outcomes of Use of the Porous Glass Membrane Pumping Emulsification Device During Transarterial Chemoembolization for Hepatocellular Carcinoma

  FUMITAKA MIZUNO, NORIHIRO IMAI, KAZUYUKI MIZUNO, SHINYA YOKOYAMA, KENTA YAMAMOTO, TAKANORI ITO, YOJI ISHIZU, TAKASHI HONDA and HIROKI KAWASHIMA

  Anticancer Research July 2024, 44 (7) 3185-3191; DOI: https://doi.org/10.21873/anticanres.17133
• You have access

  Return to Work After Breast Cancer Treatment: An Electronic Health Record-based Study in North Norway

  CARSTEN NIEDER, ELLINOR C. HAUKLAND and BÅRD MANNSÅKER

  Anticancer Research July 2024, 44 (7) 3193-3198; DOI: https://doi.org/10.21873/anticanres.17134
• You have access

  Advanced Cholangiocarcinoma With High Tumor Mutation Burden Achieving Complete Response to Immune Check Point Inhibitor

  HIROHISA OKABE, TOSHIRO MASUDA, HIDETOSHI NITTA, MASAHIRO TOMITA, ASUKA ONO, DAISUKE KURODA, HIDEYUKI KUROKI, MASAHIKO HIROTA, TAIZO HIBI, HIDEO BABA and HIROKI SUGITA

  Anticancer Research July 2024, 44 (7) 3199-3203; DOI: https://doi.org/10.21873/anticanres.17135
• You have access

  Combined Pubic Arch and Ischial Bone Resection for Metachronous and Frequent Local Recurrences of Rectal Cancer

  KOJI KOMORI, MASAHIRO YOSHIDA, SATOSHI TSUKUSHI, TAKASHI KINOSHITA, YUSUKE SATO, AKIRA OUCHI, SEIJI ITO, TETSUYA ABE, KAZUNARI MISAWA, YUICHI ITO, SEIJI NATSUME, EIJI HIGAKI, TOMONARI ASANO, MASATAKA OKUNO, HIRONORI FUJIEDA, HISAHUMI SAITO, KIYOSHI NARITA, TAKUYA KITAHARA, TAKAAKI HANAZAWA, HIDENORI OJIO, MASASHI NEGITA, HIRONOBU YASUOKA and YASUHIRO SHIMIZU

  Anticancer Research July 2024, 44 (7) 3205-3211; DOI: https://doi.org/10.21873/anticanres.17136
• You have access

  Mesna, Doxorubicin, Ifosfamide and Dacarbazine (MAID) Combination Chemotherapy for Retroperitoneal Sarcoma: A Single-center Experience

  YUDAI ISHIYAMA, TORU INAKAWA, MAKI YOSHINO, KOICHI NISHIMURA, TOSHIHIDE HORIUCHI, HIROKI ISHIHARA, DAISUKE TOKI and TSUNENORI KONDO

  Anticancer Research July 2024, 44 (7) 3213-3220; DOI: https://doi.org/10.21873/anticanres.17137